Cargando…
Dysuria therapeutic agents as an independent prognostic factor for the primary recurrence of non-muscle invasive bladder cancer: a propensity score matching study
OBJECTIVE: To investigate if the use of therapeutic agents for dysuria is a risk factor for the primary recurrence of non-muscle invasive bladder cancer (NMIBC). METHODS: First, patients with NMIBC were divided into two groups: the non-recurrence group and the recurrence group. Patient characteristi...
Autores principales: | Kato, Yoichiro, Ikarashi, Daiki, Kikuchi, Daichi, Takayama, Misato, Kanzaki, Seiko, Ito, Akito, Tamura, Daichi, Matsuura, Tomohiko, Maekawa, Shigekatsu, Kato, Renpei, Kanehira, Mitsugu, Takata, Ryo, Sugimura, Jun, Obara, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381433/ https://www.ncbi.nlm.nih.gov/pubmed/34407681 http://dx.doi.org/10.1177/03000605211037478 |
Ejemplares similares
-
Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational study
por: Takata, Ryo, et al.
Publicado: (2021) -
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer
por: Kato, Renpei, et al.
Publicado: (2020) -
Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting
por: Kato, Renpei, et al.
Publicado: (2020) -
Appropriate preoperative membranous urethral length predicts recovery of urinary continence after robot-assisted laparoscopic prostatectomy
por: Ikarashi, Daiki, et al.
Publicado: (2018) -
Metastatic bladder cancer forming a sigmoidorectal fistula after enfortumab vedotin therapy: a case report
por: Tamada, Shinji, et al.
Publicado: (2023)